US 9150500
Neprilysin inhibitors
granted A61KA61K31/16A61K31/164
Quick answer
US patent 9150500 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/16, A61K31/164, A61K31/165, A61K31/166